A breakthrough will never save a life if it never makes its way out of the lab and into the real world. This core works with community members, researchers, government, and industry to apply scientific discoveries to real-world uses, products, medications, and policies to improve your life. The core also houses the ITM Pilot Award program that gives seed funding to accelerate an idea that could improve people’s health.
ITM Translational Endeavors Core Leader
Eric Beyer, MD, PhD, leads the ITM’s Career Development and Translational Endeavors cores, where he oversees the ITM’s training and education programs and initiatives.
Beyer, a professor of pediatrics, cell physiology, cancer biology, and molecular medicine, is a renowned expert in childhood cancers and blood diseases. He has presented at numerous conferences and seminars around the world. He runs an internationally-recognized molecular and cellular biology lab that’s widely known for making major contributions to the field and focuses on intercellular communication research, which could lead to new cancer treatments.
His work studying how to develop new molecular approaches to cancer therapy also helps pave the way for new or improved treatments for heart problems and cataracts. He has authored or co-authored more than 170 publications on these topics. In addition to his extensive cancer research, Beyer has been recognized as a top doctor by Chicago magazine.
Reach him at EBeyer@peds.bsd.uchicago.edu.